MedTrace Logo

Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease

NCT00006399 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2009-01-15

No results posted yet for this study

Summary

The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning.

Conditions

  • Alzheimer Disease

Interventions

DRUG

Donepezil

DRUG

Estrogen

DRUG

Progesterone

Sponsors & Collaborators

  • Alzheimer's Association

    collaborator OTHER

  • Pfizer

    collaborator INDUSTRY

  • Eisai Inc.

    collaborator INDUSTRY

  • National Center for Research Resources (NCRR)

    lead NIH

Principal Investigators

  • Paul A. Newhouse, M.D. · Memory Center, Department of Psychiatry, University of Vermont College of Medicine

Study Design

Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-09-30
Primary Completion
2004-03-31
Completion
2004-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00006399 on ClinicalTrials.gov